Private equity boost for Chase Templeton

Chase Templeton Group, the Blackburn-based specialist private medical insurance specialist  intermediary, has secured investment from  Palatine Private Equity.

The company is the major consolidator in the sector and the move secures the firm’s acquisition strategy.

Kevin Amphlett, chairman of Chase Templeton, said: "It became clear that attracting professional investment was the most efficient way of fuelling our ambitious growth plans. After considering various offers, Palatine were chosen for their enthusiastic approach and deep understanding of our buy-and-build strategy.

“Our senior management team have been put through the most rigorous of due diligence processes lasting many months and it is testament to the strength of our organisation that we came through this unscathed whilst still delivering exceptional bottom line growth in the toughest of market conditions.”

Ed Fazakerley, partner at manchester-based Palatine Private Equity, said: “Kevin and the Chase management team have grown the business to become a leading player in a very competitive environment. The investment will allow the business to continue with its buy-and-build strategy and will further strengthen its position in the market. We are excited about working with such an ambitious team and a great business.”